[Fibrinolysis and thrombosis of mechanical valvular prosthesis: risk stratification by transesophageal

R Roudaut1, S Lafitte, M F Roudaut

  • 1Hôpital cardiologique du Haut-Lévêque, CHU de Bordeaux, 33604 Pessac.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|December 5, 2002
PubMed

Insights

Transesophageal echocardiography aids risk stratification for mechanical heart valve thrombosis. Large, mobile thrombi indicate fibrinolysis is less effective and carries higher risks, suggesting it may be a contraindication.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Interventional Cardiology

Background:

  • Fibrinolysis for mechanical heart valve thrombosis remains debated.
  • Transesophageal echocardiography (TEE) is crucial for assessing cardiac structures.

Purpose of the Study:

  • To define the role of TEE in risk stratification for mechanical heart valve thrombosis.
  • To evaluate the effectiveness and safety of fibrinolysis based on TEE findings.

Main Methods:

  • A monocentric study of 49 patients with mechanical heart valve thrombosis treated with fibrinolysis.
  • TEE was performed prior to thrombolysis to characterize thrombus size, mobility, and obstruction.
  • Outcomes (clinical events, fibrinolysis success) were analyzed based on thrombus characteristics.

Main Results:

  • Complete fibrinolysis success was 69.4% overall.
  • Thrombus size significantly impacted success rates (88% for <10 mm vs. 35% for ≥10 mm, p < 0.01).
  • Mobile thrombi were associated with a higher rate of systemic emboli (p < 0.01).

Conclusions:

  • TEE is significant in guiding therapeutic choices for valvular prosthesis thrombosis.
  • Voluminous and mobile thrombi are contraindications for fibrinolysis due to increased risks and lower success rates.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...